Although Wip1 was not a prognostic marker (the p value was 0.061), patients with ovarian cancer harbouring high Wip1 expression showed a favourable 5-year survival rate compared with those with low expression (43% vs. 29%). This evidence concerns the gene PPM1D and ovarian carcinoma.